Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma-Reference-Cited by-同舟云学术

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma

Published:2014-01-13 Issue:4 Volume:10 Page:970-976
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Shimizu Koichi,Kotera Yoshihito,Aruga Atsushi,Takeshita Nobuhiro,Katagiri Satoshi,Ariizumi Shun-ichi,Takahashi Yutaka,Yoshitoshi Kenji,Takasaki Ken,Yamamoto Masakazu

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.27678

Reference28 articles.

1. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

2. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

3. Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

4. Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma

5. Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies;International Journal of Molecular Sciences;2024-06-21

2. Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles;Pathology - Research and Practice;2024-04

3. Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2024-03-27

4. Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review);International Journal of Oncology;2023-10-27

5. Consensus on the tertiary prevention of primary liver cancer;Hepatology International;2023-06-27